These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9207281

  • 21. Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy X-ray absorptiometry.
    Shiomi S, Kuroki T, Masaki K, Takeda T, Nishiguchi S, Nakajima S, Seki S, Kobayashi K, Okamura T, Ochi H.
    J Gastroenterol; 1994 Oct; 29(5):605-9. PubMed ID: 8000509
    [Abstract] [Full Text] [Related]

  • 22. Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.
    Geusens P, Dequeker J, Vanhoof J, Stalmans R, Boonen S, Joly J, Nijs J, Raus J.
    Ann Rheum Dis; 1998 Dec; 57(12):724-7. PubMed ID: 10070271
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T, McGuigan L, Barbagallo S, Bryant C.
    Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
    [Abstract] [Full Text] [Related]

  • 25. Non-invasive assessment of bone density in primary biliary cirrhosis.
    Pereira SP, Bray GP, Pitt PI, Li F, Moniz C, Williams R.
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):323-8. PubMed ID: 10333207
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury.
    Pearson EG, Nance PW, Leslie WD, Ludwig S.
    Arch Phys Med Rehabil; 1997 Mar; 78(3):269-72. PubMed ID: 9084348
    [Abstract] [Full Text] [Related]

  • 30. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H, Risedronate Phase III Research Group.
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [Abstract] [Full Text] [Related]

  • 31. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
    Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH.
    Am J Med; 1993 Dec; 95(6):557-67. PubMed ID: 8259772
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
    Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.
    N Engl J Med; 1997 Aug 07; 337(6):382-7. PubMed ID: 9241127
    [Abstract] [Full Text] [Related]

  • 34. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
    Crilly RG, Sebaldt RJ, Hodsman AB, Adachi JD, Brown JP, Goldsmith CH, Hanley DA, Olszynski WO, Ste-Marie LG, Stephenson GF.
    Osteoporos Int; 2000 Aug 07; 11(7):607-14. PubMed ID: 11069195
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
    Frost ML, Cook GJ, Blake GM, Marsden PK, Benatar NA, Fogelman I.
    J Bone Miner Res; 2003 Dec 07; 18(12):2215-22. PubMed ID: 14672357
    [Abstract] [Full Text] [Related]

  • 37. Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Yonsei Med J; 2005 Dec 31; 46(6):750-8. PubMed ID: 16385649
    [Abstract] [Full Text] [Related]

  • 38. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment.
    Floreani A, Chiaramonte M, Giannini S, Malvasi L, Lodetti MG, Castrignano R, Giacomini A, D'Angelo A, Naccarato R.
    J Hepatol; 1991 Mar 31; 12(2):217-23. PubMed ID: 2051000
    [Abstract] [Full Text] [Related]

  • 39. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD, Roux C, Pitt PI, Cooper C, Moniz C, Dequeker J, Ioannidis G, Cawley MI, Jenkins EA, Walker-Bone KE, Pack S, Stephenson GF, Laan RF, Brown J, Geusens P.
    J Rheumatol; 2000 Oct 31; 27(10):2424-31. PubMed ID: 11036840
    [Abstract] [Full Text] [Related]

  • 40. COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
    Qureshi AM, Herd RJ, Blake GM, Fogelman I, Ralston SH.
    Calcif Tissue Int; 2002 Mar 31; 70(3):158-63. PubMed ID: 11907712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.